MedPath

Neuromuscular Responses to Acute Beetroot Ingestion in Women Older Adults

Not Applicable
Completed
Conditions
Dietary Supplement
Placebo
Interventions
Dietary Supplement: beetroot juice
Registration Number
NCT05337527
Lead Sponsor
Universidad Francisco de Vitoria
Brief Summary

Beetroot juice supplementation has shown the capacity for provoking different physiological effects (e.g. vasodilation and muscle contraction increments). However, the effects of beetroot juice ingestion on neuromuscular performance in women older adults are barely studied. In this randomized placebo-controlled study, we investigated the effects of beetroot acute supplementation in improving neuromuscular performance in women older adults

Detailed Description

Beetroot juice supplementation has shown the capacity for provoking different physiological effects that could affect human performance (e.g. vasodilation and muscle contraction increments). Although this dietary supplement has been commonly used for improving sports performance in recreational or professional athletes, the scientific literature in older adults is scarce. Thus, in our knowledge, no previous studies have analyzed the side effects associated to ingestion in this population group. In this randomized placebo-controlled study, we investigated the effects of beetroot acute supplementation in improving neuromuscular performance and side effects associated with ingestion in women older adults.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • Women >65 or <85 years of age.
  • In good health, as determined by the investigator's review of history.
Exclusion Criteria

(based in previous studies on this topic (doi: 10.1093/gerona/glaa311).

Men and women <65 or >85 years of age Unable to provide informed consent Current smokers Significant orthopedic limitations or other contraindications to strenuous exercise Those taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy Those taking anti-coagulants or on anti-platelet therapy History of neuromuscular disease (e.g., cervical spondylotic radiculomyelpathy, lumbar spondylosis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, and acquired demyelinating polyneuropathies) Cardiovascular disease (e.g., > stage I hypertension, heart failure, myocardial infarction/ischemia significant myocardial or pericardial diseases (e.g. amyloidosis, constriction), Moderate or severe valvular disease, renal disease, liver disease, or anemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Beetroot supplementationbeetroot juiceOne serving 70 mL of beetroot juice (6.4 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session.
Placebo supplementationbeetroot juiceOne serving 70 mL of beetroot juice placebo (0.04 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session.
Primary Outcome Measures
NameTimeMethod
Changes in maximal isometric handgrip strength (N)1-week

Using a dynamometer and measuring dominant/ non-dominant side

Changes in Sit and Stand Test1-week

Using Power Frail APP

Changes in Time Up and Go test1-week

Using a photocell timing gates (seconds)

Changes in 6-m gait speed test1-week

Using a photocell timing gates (seconds)

6-Minute Walk Test1-week
Secondary Outcome Measures
NameTimeMethod
Side effects questionnarie1-week

Using a side-effects questionnarie (YES/NO scale)

Rate of perception effort (RPE)1-week

Using a validated scale (1-10 points)

Trial Locations

Locations (1)

Universidad Francisco de Vitoria

🇪🇸

Pozuelo de Alarcón, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath